Sagittal abdominal diameter and visceral adiposity: Correlates of beta-cell function and dysglycemia in severely obese women

Obesity Surgery

Volumn 23, Issue 7, 2013, Pages 874-881

  Gletsu Miller, Nana ^a   Kahn, Henry S ^b   Gasevic, Danijela ^c   Liang, Zhe ^d   Frediani, Jennifer K ^d   Torres, William E ^d   Ziegler, Thomas R ^d   Phillips, Lawrence S ^d   Lin, Edward ^d  

^a PURDUE UNIVERSITY   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c SIMON FRASER UNIVERSITY   (Canada)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anthropometry; Insulin resistance; Intra abdominal fat; Obesity; Sagittal abdominal diameter; Type 2 diabetes; Waist circumference

Indexed keywords

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CONTROLLED STUDY; DYSGLYCEMIA; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SAGITTAL ABDOMINAL DIAMETER; WAIST CIRCUMFERENCE;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; INTRA-ABDOMINAL FAT; LONGITUDINAL STUDIES; MULTIDETECTOR COMPUTED TOMOGRAPHY; OBESITY, MORBID; PREDICTIVE VALUE OF TESTS; ROC CURVE; SAGITTAL ABDOMINAL DIAMETER; UNITED STATES; WAIST CIRCUMFERENCE;

EID: 84878874110     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-013-0874-6     Document Type: Article

References (42)

1. Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303:235-41.
2. Knowler WC, Pettit DJ, Savage PJ, et al. Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol. 1981;11:144-56.
3. Gregg EW, Cheng YJ, Narayan KMV, et al. The relative contribution of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004. Prev Med. 2007;45:348-52.
4. Wang Y, Rimm EB, Stampfer MJ, et al. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr. 2005;81:555-63.
5. Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012;308:1150-9.
6. Wagenknecht LE, Langefeld CD, Scherzinger AL, et al. Insulin sensitivity, insulin secretion, and abdominal fat. The insulin resistance atherosclerois study (IRAS) Family Study. Diabetes. 2003;52:2490-6.
7. Utzschneider KM, Carr DB, Hull RL, et al. Impact of intraabdominal fat and age on insulin sensitivity and β-cell function. Diabetes. 2004;53:2867-72.
8. Goodplaster BH, Kelley DE, Wing RR, et al. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes. 1999;48:839-47.
9. Hanley AJG, Wagenknecht L, Norris JM, et al. Insulin resistance, beta-cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Familiy Study. Diabetologia. 2009;52:2079-86.
10. Pajunen P, Rissanen H, Laaksonen MA, et al. Sagittal abdominal diameter as a new predictor for incident diabetes. Diabetes Care. 2013;36:283-88.
11. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes. 1993;42:1663-72.
12. Cnop M, Landchild MJ, Vidal J, et al. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin compartments: distinct metabolic effects of two fat compartments. Diabetes. 2002;51:1005-15.
13. Lin E, Phillips LS, Ziegler TR, et al. Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss. Diabetes. 2007;56:735-42.
14. Le K-A, Ventura EE, Fisher JQ, et al. Ethnic differences in pancreatic fat accumulation and its relationship with other fat depots and inflammatory markers. Diabetes Care. 2011;34:485-90.
15. Heni M, Machann J, Staiger H, et al. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev. 2010;26:200-5.
16. Kamel EG, McNeill G, Van Wijk MCW. Usefulness of anthropometry and DXA in predicting intra-abdominal fat in obese men and women. Obes Res. 2000;8:36-42.
17. Zamboni M, Turcato E, Armellini F, et al. Sagittal abdominal diameter as a practical predictor of visceral fat. Int J Obes. 1998;22:655-60.
18. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735-52.
19. Lemieux S, Prud'homme D, Tremblay A, et al. Anthropometric correlates to changes in visceral adipose tissue over 7 years in women. Int J Obes. 1996;20:618-24.
20. Kamel EG, McNeill G, Van Wijk MCW. Change in intra-abdominal adipose tissue volume during weight loss in obese men and women: correlation between magnetic resonance imaging and anthropometric measurements. Int J Obes. 2000;24:607-13.
21. Drapeau V, Lemieux I, Richard D, et al. Waist circumference is useless to assess the prevalence on metabolic abnormalities in severely obese women. Obes Surg. 2007;17:905-9.
22. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30:S42-7.
23. Bergman RN. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes. 1989;38:1512-27.
24. Haffner SM, Howard G, Mayer E, et al. Insulin sensitivity and acute insulin response in African Americans, Non-Hispanic Whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes. 1997;46:63-9.
25. Garcia-Fuentes E, Garcia-Almeida JM, Garcia-Arnes J, et al. Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery. Obes Surg. 2006;16:1179-88.
26. Lin E, Liang Z, Frediani J, et al. Improvement in beta-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery. Am J Physiol Endocrinol Metab. 2010;299:E706-12.
27. Gan SK, Kriketos AD, Poynten AM, et al. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. Obes Res. 2003;11:1295-305.
28. Gastaldelli A, Sironi AM, Ciociaro D, et al. Visceral fat and beta-cell function in non-diabetic humans. Diabetologia. 2005;48:2090-6.
29. Macor C, Ruggeri A, Mazzenetto P, et al. Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity. Metab Clin Exp. 1997;46:123-9.
30. Goran MI, Lane C, Toledo-Corral C, et al. Persistence of pre-diabetes in overweight and obese Hispanic children. Association with progressive insulin resistance, poor B-cell function, and increasing visceral fat. Diabetes. 2008;57:3007-12.
31. Maedler K, Oberholzer J, Bucher P, et al. Monounsaturated fatty acids prevent the deleterious effects of palmitate and high glucose on human pancreatic beta-cell turnover and function. Diabetes. 2003;52:726-33.
32. Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012;367:695-704.
33. Nordhamn K, Sodergren E, Olsson E, et al. Reliability of antropometric measurements in overweight and lean subjects: consequences for correlations between anthropometrics and other variables. Int J Obes. 2000;24:652-7.
34. Sjostrom L, Lonn L, Chowdhury B, et al. The sagittal diameter is a valid marker of the visceral adipose tissue volume. In: Angel A, Anderson H, Bouchard B, Lau D, Leiter L, Mendelson R, editors. Progress in obesity research. Herts, United Kingdom: John Libbey & Company Ltd.; 1996. pp. 309-19.
35. Sampaio LR, Simoes EJ, Assis AMO, et al. Validity and reliability of the sagittal abdominal diameter as a predictor of visceral abdominal fat. Arq Bras Endocrinol Metab. 2007;51:980-6.
36. Yim JY, Kim D, Lim SH, et al. Sagittal abdominal diameter is a strong anthropometric measure of visceral adipose tissue in the Asian general population. Diabetes Care. 2010;33:2665-70.
37. Salmenniemi U, Ruotsalainen E, Vanttinen M, et al. High amount of visceral fat mass is associated with multiple metabolic changes in offspring of type 2 diabetic patients. Int J Obes. 2005;29:1464-70.
38. Nakata K, Choo J, Hopson MJS, et al. Stronger associations of sagittal abdominal diameter with atherogenic lipoprotein subfractions than waist circumference in middle-aged US white and Japanese men. Metab Clin Exp. 2010;59:1742-51.
39. Riserus U, Arnlov J, Brismar K, et al. Sagittal abdominal diameter is a strong anthropometric marker of insulin resistance and hyperproinsulinemia in obese men. Diabetes Care. 2004;27:2041-6.
40. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care. 2010;33:562-8.
41. Muniyappa R, Lee S, Chen H, et al. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294:E15-26.
42. Sjostrom L. A computer-tomography based multicomponent body composition technique and anthropometric predictions of lean body mass, total and subcutaneous adipose tissue. Int J Obes. 1991;1991:19-30.